Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years

Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years

IntroductionAllogeneic hematopoietic cell transplantation (alloHCT) possessed direct cytotoxicity and graft-versus-multiple myeloma effect (GvMM). Growing trials have shown survival benefits of performing alloHCT in both newly diagnosed and relapsed MM.MethodsWe aimed to provide a comprehensive anal...

Full description

Saved in:

Bibliographic Details
Main Authors:	Si Yu Lin, Ke Jie Lu, Xiao Na Zheng, Jian Hou, Ting Ting Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-07-01
Series:	Frontiers in Oncology
Subjects:	multiple myeloma allogeneic stem cell transplantation response rate survival outcome OS PFS
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1341631/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Corrigendum: Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years
by: Si Yu Lin, et al.
Published: (2025-03-01)

Multiple Myeloma Complicated With Bronchiolitis Obliterans Syndrome After Allogeneic Haematopoietic Stem Cell Transplantation and Subsequently Underwent Lung Transplantation Successfully: A Case Report
by: Shih‐Wei Huang, et al.
Published: (2025-03-01)

Construction and validation of an 18F-FDG-PET/CT-based prognostic model to predict progression-free survival in newly diagnosed multiple myeloma patients
by: Xiaoqing Dong, et al.
Published: (2024-12-01)

IMPACT OF PRETRANSPLANT DONOR AND RECIPIENT CYTOMEGALOVIRUS SEROSTATUS ON OUTCOME FOR MULTIPLE MYELOMA PATIENTS UNDERGOING REDUCED INTENSITY CONDITIONING ALLOGENEIC STEM CELL TRANSPLANTATION.
by: Jean Elcheikh
Published: (2013-04-01)

Prognosis of Tyrosine Kinase Inhibitor Therapy for Non-Small Cell Lung Cancer
by: Agus Andreas Santoso, et al.
Published: (2025-05-01)

Outcomes of Allogeneic Stem Cell Transplant in Chronic Myeloid Leukemia-Blast Phase: A Single-Center Experience from South India
by: Thejeswar Nakka, et al.
Published: (2025-06-01)

Monitoring of chimerism after allogeneic hematopoietic stem cell transplantation
by: D. S. Dubnyak, et al.
Published: (2022-12-01)

Autologous stem cell transplantation in the treatment of multiple myeloma single center experience
by: Marjanović Slobodan, et al.
Published: (2011-01-01)

LYMPHOID NEOPLASMS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION. THE CASE OF SECONDARY HODGKIN’S LYMPHOMA, DIFFERENTIAL DIAGNOSIS WITH POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE
by: Yu. V. Skvortsova, et al.
Published: (2017-06-01)

Recent advancements in hematopoietic stem cell transplantation in Taiwan
by: Chi-Cheng Li, et al.
Published: (2024-01-01)

Analysis of risk factors for relapse after allogeneic hematopoietic stem cell transplantation in acute leukemia
by: Jiawen Wang, et al.
Published: (2025-12-01)

Safety and Efficacy of Alectinib in the First Line for ALK-Mutated Lung Cancer: A Real-World Data from India
by: Ajaykumar Singh, et al.

Recommendations for (Pharmaco)Genetic Sampling in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation
by: Anniek Bokma, et al.
Published: (2025-08-01)

Pulmonary complications in children and adolescents after allogeneic hematopoietic stem cell transplantation
by: A. S. Frolova, et al.
Published: (2022-11-01)

Optimizing Timing and Preparation for Allogeneic Hematopoietic Stem Cell Transplantation in Higher-Risk Myelodysplastic Syndromes
by: Geng L, et al.
Published: (2025-08-01)

Kidney Transplantation After Allogeneic Hematopoietic Cell Transplantation
by: Marie-Julia Ziliotis, et al.
Published: (2024-04-01)

Outcomes of Allogeneic Stem Cell Transplant in Patients with Relapsed/Refractory Hodgkin Lymphoma
by: Shiliang Ge, et al.
Published: (2025-02-01)

Results of allogeneic hematopoietic stem cell transplantation in a patient with classical Hodgkin's lymphoma
by: A. Р. Strelnikova, et al.
Published: (2021-05-01)

Bloodstream infections in different stage of reconstitution after first allogeneic hematopoietic stem cell transplantation
by: M. I. Akhmedov, et al.
Published: (2022-01-01)

Bacterial infections in pediatric and adolescent in allogeneic hematopoietic stem cell transplantation recipients: etiology, structure, risk factors
by: M. Yu. Averyanova, et al.
Published: (2014-09-01)

Allogeneic hematopoietic stem cell transplantation for mucopolysaccharidosis patients: a single-center experience and assessment of quality of life
by: Wen Zhang, et al.
Published: (2025-03-01)

Healthcare Resource Use and Costs of Allogeneic Hematopoietic Stem Cell Transplantation Complications: A Scoping Review
by: Nancy V. Kim, et al.
Published: (2025-05-01)

Posttransplant Erythrocytosis after Allogenic Stem Cell Transplant for Acute Myeloid Leukemia: A Case Report and Review of Literature
by: Sherry S. Abraham, et al.

SECONDARY SOLID TUMORS IN CHILDREN AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION: CASE REPORTS AND LITERATURE REVIEW
by: Yu. V. Skvortsova, et al.
Published: (2017-06-01)

Invasive aspergillosis caused by <i>Aspergillus non-fumigatus</i> after allogeneic hematopoietic stem cell transplantation
by: V. V. Markelov, et al.
Published: (2023-01-01)

Major histocompatibility complex: history of discovery, evolution, structure, significance in transplantation of allogeneic hematopoietic stem cells
by: F. A. Omarova, et al.
Published: (2023-06-01)

Risk factors of CMV replication after allogeneic hematopoietic stem cell transplantation in children and adolescents
by: S. N. Shiriaev, et al.
Published: (2014-09-01)

Four cases of renal injury associated with allogeneic haematopoietic stem cell transplantation and literature review
by: Dong Ze-xuan, et al.
Published: (2025-01-01)

Therapy efficacy in multiple myeloma patients received autologous stem cells transplantation as first line therapy
by: Ye. I. Darskaya, et al.
Published: (2014-07-01)

Advances in allogeneic hematopoietic stem cell transplantation for Langerhans cell histiocytosis in children
by: Guangqiang Meng, et al.
Published: (2025-01-01)

Regulatory T-cells and allogeneic hematopoietic stem cell transplantation
by: O. S. Karavaeva, et al.
Published: (2022-12-01)

Analysis of the results of allogeneic hematopoietic stem cell transplantation depending on HLA matching of the unrelated donor / recipient pair
by: Ye. V. Kuzmich, et al.
Published: (2015-01-01)

Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma in the Era of New Drugs
by: OV Pirogova, et al.
Published: (2018-04-01)

Advancing the pathway to allogeneic hematopoietic stem cell transplantation through a physician–nurse coordinator system in patients with acute leukemia
by: Chidapa Auepisit, et al.
Published: (2025-07-01)

Thrombotic events in patients with multiple myeloma and their impact on overall survival
by: Haimin Chen, et al.
Published: (2025-12-01)

Autologous Bone Marrow Transplant in Multiple Myeloma Patient With Bone Marrow Hematopoietic Stem Cell
by: D Santosa, et al.
Published: (2020-12-01)

Autologous Bone Marrow Transplant in Multiple Myeloma Patient With Bone Marrow Hematopoietic Stem Cell
by: D Santosa, et al.
Published: (2020-12-01)

Therapeutic effects of non-preconditioning allogeneic hematopoietic stem cell transplantation on acute radiation injury
by: Liren Qian, et al.
Published: (2025-04-01)

Bone Mineral Turnover after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Single Center Cohort Study
by: Yuliya V. Skvortsova, et al.
Published: (2018-01-01)

VZV Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation in Children: When to Stop?
by: Eva deBerranger, et al.
Published: (2024-11-01)